FDA approves Alzheimer’s drug Leqembi from Eisai, Biogen
The Food and Drug Administration on Thursday fully approved the Alzheimer’s treatment Leqembi, a pivotal decision that will expand access to the expensive drug for older Americans. Medicare announced shortly …
